TaiMed Biologics Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	898.38	580.23	251.01	274.11	551.62
Short-Term Investments	872.35	1,072	395.49	309.93	406.68
Trading Asset Securities	-	-	-	58.75	-
Cash & Short-Term Investments	1,771	1,652	646.5	642.79	958.3
Cash Growth	7.17%	155.58%	0.58%	-32.92%	-20.21%
Accounts Receivable	79.06	103.02	160.49	98.24	157.78
Other Receivables	17.04	31.3	28.16	25.49	35.41
Receivables	96.1	134.31	188.65	123.73	193.19
Inventory	827.73	1,569	1,271	1,389	1,177
Prepaid Expenses	-	6.41	10.01	4.15	3.54
Other Current Assets	627.75	31.16	35.63	5.08	2.59
Total Current Assets	3,322	3,394	2,151	2,165	2,335
Property, Plant & Equipment	807.39	857.4	908.26	957.74	1,011
Long-Term Investments	15.72	-	0.9	43.44	232.63
Other Intangible Assets	442.15	539.4	625.79	724.38	821.33
Other Long-Term Assets	223.18	208.79	207.58	210.57	211.19
Total Assets	4,811	4,999	3,894	4,101	4,611
Accounts Payable	81	0.76	13.5	0.09	122.58
Accrued Expenses	-	11.63	7.49	39.39	51.64
Short-Term Debt	-	-	200	200	-
Current Portion of Long-Term Debt	32	27.24	26.97	14.32	-
Current Portion of Leases	2.29	2.26	2.18	2.02	1.95
Current Unearned Revenue	106.29	74.32	91.12	57.48	24.34
Other Current Liabilities	31.93	18.56	19.92	16.57	24.57
Total Current Liabilities	253.51	134.77	361.17	329.86	225.08
Long-Term Debt	440.19	468.03	495.04	521.68	536
Long-Term Leases	22.81	25.1	26.67	28.12	29.38
Long-Term Unearned Revenue	236.55	347.53	444.04	505.6	877.9
Other Long-Term Liabilities	-	0.92	0.92	0.92	0.87
Total Liabilities	953.05	976.34	1,328	1,386	1,669
Common Stock	2,732	2,731	2,530	2,526	2,523
Additional Paid-In Capital	2,469	2,452	986.67	945.45	925.14
Retained Earnings	-1,304	-1,136	-934.56	-740.22	-470.93
Comprehensive Income & Other	-38.88	-23.89	-16.13	-15.83	-35.97
Shareholders' Equity	3,858	4,023	2,566	2,715	2,942
Total Liabilities & Equity	4,811	4,999	3,894	4,101	4,611
Total Debt	497.28	522.63	750.86	766.14	567.32
Net Cash (Debt)	1,273	1,130	-104.35	-123.35	390.98
Net Cash Growth	12.73%	-	-	-	-38.12%
Net Cash Per Share	4.63	4.21	-0.41	-0.49	1.55
Filing Date Shares Outstanding	280.74	273.08	253.01	252.55	252.33
Total Common Shares Outstanding	280.74	273.08	253.01	252.55	252.33
Working Capital	3,069	3,259	1,790	1,835	2,110
Book Value Per Share	13.74	14.73	10.14	10.75	11.66
Tangible Book Value	3,416	3,484	1,940	1,991	2,120
Tangible Book Value Per Share	12.17	12.76	7.67	7.88	8.40
Land	-	194.61	194.61	194.61	194.61
Buildings	-	495.41	493.95	493.54	493.12
Machinery	-	457.35	455.56	450.03	446.9
Leasehold Improvements	-	4.64	4.64	4.64	4.64

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.